 | |
- close
- close
|
Stock Blog Hub
Dec 5
Comment
Par Pharmaceutical Cos. (PRX) continues to climb as analysts raise estimates on another earnings surprise.
Company Description
Par Pharmaceutical makes generic drugs and other branded pharmaceuticals. Currently, the company has 4 trademarked...
PR Newswire
Nov 25
Comment
WOODCLIFF LAKE, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced the results of its "Modified Dutch Auction" tender offer, in which Par offered to purchase, for cash, up to $65,000,000 aggregate
PR Newswire
Nov 16
Comment
WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) will hold an Analyst Day from 9:00am to 12:00pm EST on December 3, 2009 at its Spring Valley, NY manufacturing facility. Chairman, President and
PR Newswire
Nov 16
Comment
WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for the
PR Newswire
Nov 9
Comment
WOODCLIFF LAKE, N.J., Nov. 9 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has extended the expiration date and increased the purchase price of its previously announced "Modified Dutch Auction"
PR Newswire
Nov 6
Comment
WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the third quarter ended October 3, 2009. For the third quarter ended October 3, 2009, Par reported total revenues of
PR Newswire
Oct 22
Comment
WOODCLIFF LAKE, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Friday, November 6, 2009 at 9:00 am EST to review results for the third
Stock Blog Hub
Oct 21
Comment
Par Pharmaceutical Companies, Inc. (PRX) has surprised on the Zacks Consensus Estimate 3 out of the last 4 quarters by an average of 101.93%. With earnings estimates jumping, the company has a PEG ratio of just 0.2.
Company Description
Par...
Stock Blog Hub
Oct 20
Comment
Par Pharmaceutical Companies, Inc. (PRX) has surprised on the Zacks Consensus Estimate 3 out of the last 4 quarters by an average of 101.93%. With earnings estimates jumping, the company has a PEG ratio of just 0.2.
Company Description
Par...
Stock Blog Hub
Oct 15
Comment
Par Pharmaceutical Companies, Inc. (PRX) received a brokerage firm upgrade today, which is helping it to gain during a rather muted morning session.
In addition, PRX has been enjoying rising earnings estimates that have pushed the 2009 and 2010...
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
PRX AT A GLANCE
References
| ||||||
|
|
